173 related articles for article (PubMed ID: 35473809)
1. Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial.
Wang Y; Kong Y; Zhao HY; Zhang YY; Wang YZ; Xu LP; Zhang XH; Liu KY; Huang XJ
BMC Med; 2022 Apr; 20(1):140. PubMed ID: 35473809
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation.
Kong Y; Wang Y; Zhang YY; Shi MM; Mo XD; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ
Blood Adv; 2019 Apr; 3(8):1303-1317. PubMed ID: 31015207
[TBL] [Abstract][Full Text] [Related]
3. N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation.
Kong Y; Shi MM; Zhang YY; Cao XN; Wang Y; Zhang XH; Xu LP; Huang XJ
Am J Hematol; 2018 Jul; 93(7):931-942. PubMed ID: 29396859
[TBL] [Abstract][Full Text] [Related]
4. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
Kong Y
Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplant.
Kong Y; Song Y; Tang FF; Zhao HY; Chen YH; Han W; Yan CH; Wang Y; Zhang XH; Xu LP; Huang XJ
Br J Haematol; 2018 Mar; 180(6):863-878. PubMed ID: 29392716
[TBL] [Abstract][Full Text] [Related]
6. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Kong Y; Hu Y; Zhang XH; Wang YZ; Mo XD; Zhang YY; Wang Y; Han W; Xu LP; Chang YJ; Huang XJ
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1190-7. PubMed ID: 24792870
[TBL] [Abstract][Full Text] [Related]
7. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
8. The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.
Luo XY; Kong Y; Lv M; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Tang FF
Br J Haematol; 2023 Mar; 200(6):759-768. PubMed ID: 36464324
[TBL] [Abstract][Full Text] [Related]
9. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.
Kong Y; Chang YJ; Wang YZ; Chen YH; Han W; Wang Y; Sun YQ; Yan CH; Wang FR; Liu YR; Xu LP; Liu DH; Huang XJ
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1465-73. PubMed ID: 23879970
[TBL] [Abstract][Full Text] [Related]
10. Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation.
Chen J; Wang H; Zhou J; Feng S
Ther Adv Hematol; 2020; 11():2040620720948743. PubMed ID: 32874483
[TBL] [Abstract][Full Text] [Related]
11. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.
Kong Y; Wang YT; Cao XN; Song Y; Chen YH; Sun YQ; Wang Y; Zhang XH; Xu LP; Huang XJ
J Transl Med; 2017 Mar; 15(1):57. PubMed ID: 28292332
[TBL] [Abstract][Full Text] [Related]
12. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia.
Lin CH; Su YJ; Hsu CY; Wang PN; Teng CJ
Transpl Infect Dis; 2019 Aug; 21(4):e13096. PubMed ID: 31004545
[TBL] [Abstract][Full Text] [Related]
13. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
15. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.
Song Y; Shi MM; Zhang YY; Mo XD; Wang Y; Zhang XH; Xu LP; Huang XJ; Kong Y
Biol Blood Marrow Transplant; 2017 Jun; 23(6):906-912. PubMed ID: 28286199
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine as Prophylactic Therapy for Transplantation-Associated Thrombotic Microangiopathy: A Randomized, Placebo-Controlled Trial.
Pan T; Qi J; Tang Y; Yao Y; Chen J; Wang H; Yang J; Xu X; Shi Q; Liu Y; He X; Chen F; Ma X; Hu X; Wu X; Wu D; Han Y
Transplant Cell Ther; 2022 Nov; 28(11):764.e1-764.e7. PubMed ID: 35940529
[TBL] [Abstract][Full Text] [Related]
18. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
19. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Beelen DW; Trenschel R; Stelljes M; Groth C; Masszi T; Reményi P; Wagner-Drouet EM; Hauptrock B; Dreger P; Luft T; Bethge W; Vogel W; Ciceri F; Peccatori J; Stölzel F; Schetelig J; Junghanß C; Grosse-Thie C; Michallet M; Labussiere-Wallet H; Schaefer-Eckart K; Dressler S; Grigoleit GU; Mielke S; Scheid C; Holtick U; Patriarca F; Medeot M; Rambaldi A; Micò MC; Niederwieser D; Franke GN; Hilgendorf I; Winkelmann NR; Russo D; Socié G; Peffault de Latour R; Holler E; Wolff D; Glass B; Casper J; Wulf G; Menzel H; Basara N; Bieniaszewska M; Stuhler G; Verbeek M; Grass S; Iori AP; Finke J; Benedetti F; Pichlmeier U; Hemmelmann C; Tribanek M; Klein A; Mylius HA; Baumgart J; Dzierzak-Mietla M; Markiewicz M
Lancet Haematol; 2020 Jan; 7(1):e28-e39. PubMed ID: 31606445
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Zhang XH; Wang GX; Zhu HH; Liu YR; Xu LP; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Feng R; Fu HX; Wang M; Zhou Y; Lv M; Liu KY; Huang XJ
Ann Hematol; 2015 Oct; 94(10):1689-98. PubMed ID: 26141368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
